clavulanic acid has been researched along with amoxicillin-potassium clavulanate combination in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (24.32) | 18.7374 |
1990's | 12 (16.22) | 18.2507 |
2000's | 13 (17.57) | 29.6817 |
2010's | 17 (22.97) | 24.3611 |
2020's | 14 (18.92) | 2.80 |
Authors | Studies |
---|---|
Rolinson, JN | 1 |
Robinson, OP | 1 |
Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
Brown, BA; Pang, Y; Steele, LC; Steingrube, VA; Wallace, RJ; Zeluff, B; Zhang, Y | 1 |
Berry, V; Kernutt, I; Mizen, L; Woodnutt, G | 1 |
Cooper, CE; Slocombe, B; White, AR | 2 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Conner, CS | 1 |
Eggleston, M; Parker, RH | 1 |
Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
Boon, R; Davies, BE; Descoeudres, CE; Horton, R; Reubi, FC | 1 |
Bhattacharya, CP; Charkrabarty, AN; Dastidar, SG | 1 |
Beale, AS; Boon, RJ | 1 |
Von Kobyletzki, V | 1 |
Clarke, HL; Horton, R; Jackson, D; Lau, D; Staniforth, DH | 1 |
Casey, PA; Gstraunthaler, G; Pfaller, W; Semenitz, E | 1 |
Davies, B; Horton, R; Jackson, D; Staniforth, DH | 1 |
Barry, AL; Fuchs, PC; Gavan, TL; Jones, RN; Thornsberry, C | 1 |
Casey, PA; Cooper, DL; Schaad, UB | 1 |
Rolinson, GN | 1 |
Hatzimichelakis, N; Kontomichalou, P; Makris, G; Paniara-Volika, O; Paraskevopoulou, E; Saroglou, G; Sima, A; Vassilopoulos, N | 1 |
Ulmer, WT; Zimmermann, I | 1 |
Bedenić, B; Zagar, Z | 1 |
Butruk, E; Habior, A; Walewska-Zielecka, B | 1 |
Amyes, SG; Miles, RS; Thomson, CJ | 1 |
Carceles, CM; Escudero, E; Vicente, S | 1 |
Aguilar, L; Balcabao, IP; Dal-Ré, R; Gómez-Lus, ML; Martín, M; Prieto, J | 1 |
Pajchel, G; Pawłowski, K; Tyski, S | 1 |
Bruynzeel, DP; Kamphof, WG; Rustemeyer, T | 1 |
Denis, J; Frances, C; Hoizey, G; Kaltenbach, M; Lamiable, D; Millart, H; Trenque, T | 1 |
Dammers, E; Exler, PS; Vree, TB | 1 |
Dammers, E; Van Duuren, E; Vree, TB | 2 |
Berry, V; Hoover, J; Singley, C; Woodnutt, G | 1 |
Benyamini, L; Berkovitch, M; Bortnik, O; Braunstein, R; Bulkowstein, M; Merlob, P; Stahl, B; Zimmerman, D | 1 |
Sánchez Navarro, A | 1 |
Slocombe, B; Stokes, DH; Sutherland, R; Wilkinson, MJ | 1 |
Callao, MP; Pasamontes, A | 1 |
Chaowagul, W; Chierakul, W; Dance, DA; Day, NP; Lindegardh, N; Maharjan, B; Peacock, SJ; Pongtavornpinyo, W; Short, JM; Singtoroj, T; Teparrukkul, P; Wangboonskul, J; White, NJ; Wuthiekanun, V | 1 |
Sunderland, VB; Vahdat, L | 1 |
Kim, YH; Kim, YS; Ko, JY; Ro, YS | 1 |
Ariza, A; Blanca, M; Blanca-Lopez, N; Doña, I; Mayorga, C; Rondon, C; Torres, MJ | 1 |
Al-Karadsheh, OA; Algarugly, SA; Baqain, ZH; Eimar, HA; Karaky, AE; Sawair, FA | 1 |
Baquero, F; Cantón, R; Galán, JC; Novais, A; Ripoll, A; Rodríguez-Domínguez, MJ; Turrientes, MC | 1 |
Cercenado, E; de Toro, M; García-Campello, M; Rojo-Bezares, B; Sáenz, Y; Torres, C; Undabeitia, E | 1 |
Ahuja, V; Balasubramanian, V; Balganesh, M; Bhattacharjee, D; Dinesh, N; Ganguly, S; Kumar, N; Panduga, V; Parab, M; Ramachandran, V; Reddy, J; Shandil, R; Sharma, S; Solapure, S; Vishwas, KG | 1 |
Dance, D | 1 |
Al-Nesf, M; Ibrahim, W; Mobayed, H | 1 |
Daly, AK; Farrell, J; Faulkner, L; Kim, SH; Naisbitt, DJ; Ogese, M; Park, BK; Pirmohamed, M; Saide, K; Tailor, A | 1 |
Kamiya, E; Kamiya, K; Kamiya, Y; Natsume, T; Niwa, H; Niwa, M; Saito, A; Tokura, Y | 1 |
Chlebicki, MP; Tan, CW | 1 |
Cavanaugh, JS; Cegielski, JP; Dalton, T; Ershova, J; Jou, R; Kurbatova, E; Wu, MH | 1 |
Beumer, J; Bhatnagar, S; Haralam, M; Hoberman, A; Jeong, JH; Kearney, DH; Kurs-Lasky, M; Martin, JM; Miah, MK; Muñiz, G; Nagg, JP; Paradise, JL; Pope, MA; Rockette, HE; Shaikh, N; Shope, TR; Venkataramanan, R; Zhao, W | 1 |
Batard, E; Caillon, J; Chapelet, G; Javaudin, F; Marquet, A; Montassier, E; Vibet, MA | 1 |
Caminero, JA; Mishra, GP | 1 |
De Wit, S; Payen, MC | 1 |
Ali, AA; Charoo, NA; Rahman, Z | 1 |
Kreetapirom, P; Sompornrattanaphan, M; Taweechue, AJ; Theankeaw, O; Thongngarm, T; Wongsa, C | 1 |
Daniel, S; Doron, M; Fishman, B; Koren, G; Levy, A; Lunenfeld, E | 1 |
Amaral, L; Carneiro-Leão, L; Cernadas, JR | 1 |
Choi, Y; Chung, JY; Jang, K; Lee, SW; Yoon, SH | 1 |
Burdet, C; Carette, C; Crémieux, AC; Czernichow, S; Duval, X; El-Helali, N; Hammas, K; Massias, L; Mellon, G; Mentré, F | 1 |
Bieberly, Z; KuKanich, B; KuKanich, K; Papich, MG; Woodruff, K | 1 |
Bruyneel, L; Debaveye, Y; Decock, C; Peetermans, WE; Spriet, I; Ten Haaf, N; Van Wilder, A; Vanhaecht, K | 1 |
Liu, XG; Wang, R | 1 |
Bruco, MEF; Kennard, L; Mirakian, R; Rutkowski, K; Wagner, A; Wang, XM | 1 |
Allegaert, K; Baartmans, MGA; den Butter, PCP; Driessen, GJA; Eijkemans, M; Hartwig, NG; Heidema, J; Keij, FM; Kenter, S; Kornelisse, RF; Meijssen, CB; Norbruis, OF; Qi, H; Reiss, IKM; Stam-Stigter, GM; Tramper-Stranders, GA; van Beek, RHT; van Dalen-Vink, I; van den Berg, MM; van der Meer-Kappelle, LH; van der Sluijs-Bens, J; van Driel, A; van Rooij, LGM; van Rossem, MC; von Lindern, JS | 1 |
Bio, LL; Yu, D | 1 |
Baker, D; Guardabassi, L; Kovačević, Z; Liu, F; Page, SW; Pelligand, L; Scott, M; Sivagurunathan, A; Stair, JL; Steagall, PV; Suemanotham, N | 1 |
Andrews, V; Ljungquist, O; Månsson, E; Tverring, J | 1 |
Abbo, O; Bréhin, C; Claudet, I; Dubois, D; Lemoine, C; Munzer, C; Picard, C; Ricco, L | 1 |
Aparin, PG; Emelyanova, AG; Ledov, VA; Petrova, NV; Tarasov, SA | 1 |
5 review(s) available for clavulanic acid and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Kinetics; Penicillanic Acid; Penicillin Resistance; Penicillins; Sulbactam; Ticarcillin | 1987 |
New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Clavulanic Acid; Computer Simulation; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Haemophilus influenzae; Humans; Moraxella catarrhalis; Streptococcus pneumoniae | 2005 |
Treatment and prophylaxis of melioidosis.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Melioidosis; Sulfamethoxazole; Trimethoprim | 2014 |
Efficacy of amoxicillin or amoxicillin and clavulanic acid in reducing infection rates after third molar surgery: a systematic review and meta-analysis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Molar, Third; Randomized Controlled Trials as Topic; Surgical Wound Infection | 2022 |
Shedding Light on Amoxicillin, Amoxicillin-clavulanate, and Cephalexin Dosing in Children from a Pharmacist's Perspective.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalexin; Child; Clavulanic Acid; Humans; Microbial Sensitivity Tests; Pharmacists | 2022 |
10 trial(s) available for clavulanic acid and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Bronchitis; Clavulanic Acid; Clinical Trials as Topic; Doxycycline; Drug Combinations; Humans; Middle Aged | 1981 |
Identical pattern of highly variable absorption of clavulanic acid from four different oral formulations of co-amoxiclav in healthy subjects.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Area Under Curve; Chemistry, Pharmaceutical; Chromatography, Liquid; Clavulanic Acid; Cross-Over Studies; Drug Therapy, Combination; Half-Life; Humans; Male; Mass Spectrometry | 2003 |
Variable absorption of clavulanic acid after an oral dose of 25 mg/kg of Clavubactin and Synulox in healthy dogs.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Area Under Curve; Clavulanic Acid; Cross-Over Studies; Dogs; Drug Combinations; Drug Therapy, Combination; Male; Reference Values | 2003 |
Variable absorption of clavulanic acid after an oral dose of 25 mg/kg of Clavubactin and Synulox in healthy cats.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Cats; Clavulanic Acid; Cross-Over Studies; Drug Evaluation; Drug Therapy, Combination; Fasting; Female; Tablets | 2002 |
The safety of amoxicillin/clavulanic acid and cefuroxime during lactation.
Topics: Adult; Alanine Transaminase; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aspartate Aminotransferases; Breast Feeding; Cefuroxime; Clavulanic Acid; Diarrhea, Infantile; Dose-Response Relationship, Drug; Exanthema; Female; Humans; Infant; Lactation; Mastitis; Maternal Age; Middle Aged; Prospective Studies; Respiratory Tract Infections | 2005 |
Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Basophils; Clavulanic Acid; Drug Hypersensitivity; Humans; Single-Blind Method; Skin Tests | 2010 |
Antibiotic prophylaxis and early dental implant failure: a quasi-random controlled clinical trial.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; Chi-Square Distribution; Clavulanic Acid; Dental Implantation, Endosseous; Dental Restoration Failure; Drug Combinations; Female; Humans; Male; Middle Aged; Pain, Postoperative; Postoperative Care; Preoperative Care; Surgical Wound Dehiscence; Surgical Wound Infection | 2011 |
Reduced-Concentration Clavulanate for Young Children with Acute Otitis Media.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Dermatitis; Diarrhea; Female; Humans; Infant; Infant, Newborn; Male; Otitis Media | 2017 |
Multiple-dose pharmacokinetics and safety of amoxicillin/clavulanate in healthy elderly subjects.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Healthy Volunteers; Humans | 2020 |
Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiorit
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Clavulanic Acid; Humans; Infant; Infant, Newborn; Reinfection; Research; Treatment Outcome; Young Adult | 2022 |
59 other study(ies) available for clavulanic acid and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
[The development of bacterial resistance and the role of clavulanic acid].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Cell Membrane Permeability; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Mutation | 1992 |
[The pharmacokinetics, dosage, tolerance, side effects and safety of the preparation Augmentin (a combination of amoxicillin and clavulanic acid)].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Half-Life; Humans; Time Factors | 1992 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Nocardia; Nocardia Infections | 1991 |
Penetration of amoxycillin, ticarcillin and clavulanic acid into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Biological Assay; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Humans; Infusions, Intravenous; Lymph; Rabbits; Ticarcillin | 1990 |
Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Moraxella catarrhalis; Nephelometry and Turbidimetry; Time Factors | 1990 |
Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Species Specificity; United States | 1990 |
beta-Lactamase inhibitors.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Humans; Penicillanic Acid; Sulbactam | 1985 |
[Sensitivity to clavulanic acid of Escherichia coli isolated at the Henri Mondor hospital in 1986 according to phenotypes of beta-lactam antibiotic resistance].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbenicillin; Cefotaxime; Cephalothin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Penicillin Resistance; Phenotype | 1988 |
Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Clavulanic Acids; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1988 |
Comparison of sensitivity of Mycobacterium spp. to combinations of clavulanic acid & penicillins with certain antitubercular agents.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Microbial Sensitivity Tests; Mycobacterium; Penicillins | 1988 |
Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Male; Mice; Microscopy, Electron, Scanning; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Time Factors; Wound Infection | 1987 |
Pharmacokinetic data in gynecological surgery using preoperative augmentin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Endometrium; Fallopian Tubes; Female; Genital Diseases, Female; Half-Life; Humans; Myometrium; Ovary; Postoperative Complications; Preoperative Care; Tissue Distribution | 1987 |
Augmentin bioavailability following cimetidine, aluminum hydroxide and milk.
Topics: Administration, Oral; Adult; Aluminum Hydroxide; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Cimetidine; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Humans; Metabolic Clearance Rate; Milk | 1985 |
Clavulanic acid inhibits beta-lactamases.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; United States; United States Food and Drug Administration | 1984 |
Microcalorimetric, turbidimetric, phase-contrast microscopic, and electron microscopic investigations of the actions of amoxicillin, clavulanic acid and augmentin on amoxicillin-sensitive and amoxicillin-resistant strains of Escherichia coli.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Calorimetry; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Escherichia coli; Microscopy, Electron; Microscopy, Phase-Contrast; Nephelometry and Turbidimetry; Penicillin Resistance | 1983 |
Parenteral augmentin: pharmacokinetics.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Half-Life; Humans; Hypoglycemic Agents; Infusions, Parenteral; Injections, Intravenous; Kinetics; Male; Probenecid | 1984 |
In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Bacteria; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Quality Control; Regression Analysis | 1983 |
Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Humans; Injections, Intravenous; Kinetics; Male | 1983 |
The history and background of Augmentin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Drug Combinations; Enzyme Inhibitors; Penicillin Resistance | 1982 |
Amoxicillin and clavulanic acid combination: clinical and laboratory evaluation in pulmonary infections.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; beta-Lactams; Bronchitis; Clavulanic Acid; Drug Combinations; Humans; Microbial Sensitivity Tests; Middle Aged; Pneumonia | 1982 |
Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Kinetics; Moraxella catarrhalis | 1994 |
Hepatocellular-cholestatic liver injury due to amoxycillin-clavulanic acid combination.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Female; Granuloma; Humans; Male; Middle Aged; Respiratory Tract Infections; Tonsillitis | 1994 |
Susceptibility testing with clavulanic acid: fixed concentration versus fixed ratio.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests | 1995 |
Pharmacokinetics of amoxicillin/clavulanic acid combination and of both drugs alone after intravenous administration to goats.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Goats; Half-Life; Injections, Intravenous; Penicillins | 1996 |
In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Kinetics; Penicillins; Serum Bactericidal Test; Staphylococcus aureus | 1997 |
CE versus LC for simultaneous determination of amoxicillin/clavulanic acid and ampicillin/sulbactam in pharmaceutical formulations for injections.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clavulanic Acid; Drug Therapy, Combination; Electrophoresis, Capillary; Sulbactam | 2002 |
Sensitization to clavulanic acid in Augmentin.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Cystic Fibrosis; Diagnosis, Differential; Drug Eruptions; Female; Humans; Infant; Intradermal Tests; Patch Tests; Pneumonia | 2002 |
Simultaneous determination of amoxicillin and clavulanic acid in human plasma by HPLC with UV detection.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Chromatography, High Pressure Liquid; Clavulanic Acid; Humans; Male; Spectrophotometry, Ultraviolet | 2002 |
Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Azithromycin; Clavulanic Acid; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Sprague-Dawley; Streptococcus pneumoniae | 2005 |
Bactericidal effects of amoxycillin/clavulanic acid (augmentin) against Legionella pneumophila in vitro and in tissue culture studies.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Cells, Cultured; Clavulanic Acid; Legionella pneumophila; Legionnaires' Disease; Microbial Sensitivity Tests | 1989 |
Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Clavulanic Acid; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Staphylococcus aureus | 1989 |
Sequential injection analysis for the simultaneous determination of clavulanic acid and amoxicillin in pharmaceuticals using second-order calibration.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Calibration; Clavulanic Acid; Flow Injection Analysis; Molecular Conformation; Pharmaceutical Preparations; Sensitivity and Specificity | 2006 |
Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Humans; Melioidosis; Middle Aged; Time Factors | 2006 |
Kinetics of amoxicillin and clavulanate degradation alone and in combination in aqueous solution under frozen conditions.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Catalysis; Chemical Precipitation; Chromatography, High Pressure Liquid; Clavulanic Acid; Drug Combinations; Drug Stability; Freezing; Hydrochloric Acid; Hydrogen-Ion Concentration; Kinetics; Sodium Chloride; Solutions; Temperature | 2007 |
A case of allergic contact dermatitis to clavulanic acid.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Dermatitis, Allergic Contact; Female; Hand Dermatoses; Humans; Patch Tests | 2008 |
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Clavulanic Acid; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Evolution, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Penicillanic Acid; Piperacillin; Plasmids; Selection, Genetic; Tazobactam | 2011 |
Genetic characterization of the mechanisms of resistance to amoxicillin/clavulanate and third-generation cephalosporins in Salmonella enterica from three Spanish hospitals.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clavulanic Acid; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Salmonella enterica; Salmonella Infections; Spain | 2011 |
In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Thienamycins; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Delayed clavulanic acid-induced anaphylaxis in a patient undergoing bariatric surgery.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anaphylaxis; Clavulanic Acid; Drug Hypersensitivity; Epinephrine; Humans; Hypersensitivity, Delayed; Male; Treatment Outcome | 2014 |
Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Case-Control Studies; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Clavulanic Acid; Clone Cells; Female; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Reference Values; Sampling Studies | 2015 |
Drug eruption to clavulanic acid with sparing of cellulitis-affecting site.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cefazolin; Cellulitis; Clavulanic Acid; Drug Eruptions; Female; Humans; Japan; Middle Aged; Skin Tests; T-Lymphocytes; Withholding Treatment | 2015 |
Urinary tract infections in adults.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Cystitis; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; Incidence; Male; Middle Aged; Primary Health Care; Risk Factors; Urinary Tract Infections | 2016 |
Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clofazimine; Drug Discovery; Drug Resistance, Multiple, Bacterial; Humans; Leprostatic Agents; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2017 |
Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Low-dose amoxicillin-clavulanate in drug-resistant tuberculosis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Follow-Up Studies; Humans; Meropenem; Tuberculosis, Multidrug-Resistant | 2018 |
In Reply: Synergy between amoxicillin and meropenem/clavulanate in drug-resistant tuberculosis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Humans; Meropenem; Tuberculosis, Multidrug-Resistant | 2018 |
Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin-clavulanic acid orally administered immediate-release products?
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Humans; Microbial Sensitivity Tests; Therapeutic Equivalency | 2018 |
Fatal anaphylaxis from a second amoxicillin/clavulanic acid provocation after a prior negative provocation.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anaphylaxis; Anti-Bacterial Agents; Clavulanic Acid; Humans | 2020 |
The safety of amoxicillin and clavulanic acid use during the first trimester of pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Multivariate Analysis; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Risk Factors | 2019 |
Acute Generalized Exanthematous Pustulosis Due to Clavulanic Acid.
Topics: Acute Generalized Exanthematous Pustulosis; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Humans | 2020 |
Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Humans; Obesity; Prospective Studies | 2020 |
Evaluation of urine concentrations of amoxicillin and clavulanate in cats.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Clavulanic Acid; Dogs; Escherichia coli; Microbial Sensitivity Tests | 2021 |
Timeliness of administration of amoxicillin-clavulanic acid and meropenem in a large tertiary care centre.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Humans; Meropenem; Retrospective Studies; Tertiary Care Centers | 2021 |
Amoxicillin hypersensitivity: Patient outcomes in a seven-year retrospective study.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Monobactams; Penicillin G; Penicillins; Retrospective Studies; Skin Tests | 2022 |
Quality of amoxicillin/clavulanic acid oral formulations for intended veterinary use in the UK, Malaysia, Serbia and Thailand.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acid; Dogs; Malaysia; Prospective Studies; Serbia; Tablets; Thailand; United Kingdom | 2023 |
Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI).
Topics: Adult; Amdinocillin Pivoxil; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Fever; Humans; Urinary Tract Infections | 2023 |
Non-operative treatment of acute appendicitis in children: clinical efficacy of amoxicillin-clavulanic acid in a retrospective single-centre study.
Topics: Abscess; Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Child; Child, Preschool; Clavulanic Acid; Cross-Sectional Studies; Humans; Peritonitis; Retrospective Studies; Treatment Outcome | 2023 |
Efficacy of Raphamin against Pneumococcal Infection: a Preclinical Study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Clavulanic Acid; Mice; Pneumococcal Infections; Streptococcus pneumoniae | 2023 |